“…12,13 In previous years, outbreaks had occurred in India, Pakistan, and Brazil. [14][15][16] In Bangladesh three outbreaks were reported in 2008 in 2011 and in 2017. [17][18][19] Following these waves of outbreaks spreading from east Africa to southeast Asia, chikungunya infection has been reported increasingly in travellers or workers returning from visits to their home countries during the last years.…”
Recently, several countries reported imported cases of infection with chikungunya virus (CHIKV). We report the first case of chikungunya virus infection in Morocco. A 37-year old woman returned to Morocco on 15 August 2017, after she stayed in Dhaka-Bangladesh for 18months. She developed severe arthralgias and rash, fever up to 39°c. In next day’s symptoms progressively subsided but arthralgias remained for 3weeks. Laboratory findings didn't show lymphopenia, thrombocytopenia or elevated liver transaminases. Serological tests were positive for CHIKV IgM and negative for IgG antibodies. CHIKV-RNA was detected by RT-PCR. The patient was treated with non-steroid anti-inflammatory drugs and paracetamol. After 15days of hospitalization, symptoms ameliorated but arthralgias persists. The vector is established in Morocco and since the virus is diagnosed in returning travellers, chikungunya has a potential for autochthonous transmission in Morocco, that’s why CHIKV must be included in the differential diagnosis of arthralgia in all travellers returning from countries with documented transmission of the virus.
“…12,13 In previous years, outbreaks had occurred in India, Pakistan, and Brazil. [14][15][16] In Bangladesh three outbreaks were reported in 2008 in 2011 and in 2017. [17][18][19] Following these waves of outbreaks spreading from east Africa to southeast Asia, chikungunya infection has been reported increasingly in travellers or workers returning from visits to their home countries during the last years.…”
Recently, several countries reported imported cases of infection with chikungunya virus (CHIKV). We report the first case of chikungunya virus infection in Morocco. A 37-year old woman returned to Morocco on 15 August 2017, after she stayed in Dhaka-Bangladesh for 18months. She developed severe arthralgias and rash, fever up to 39°c. In next day’s symptoms progressively subsided but arthralgias remained for 3weeks. Laboratory findings didn't show lymphopenia, thrombocytopenia or elevated liver transaminases. Serological tests were positive for CHIKV IgM and negative for IgG antibodies. CHIKV-RNA was detected by RT-PCR. The patient was treated with non-steroid anti-inflammatory drugs and paracetamol. After 15days of hospitalization, symptoms ameliorated but arthralgias persists. The vector is established in Morocco and since the virus is diagnosed in returning travellers, chikungunya has a potential for autochthonous transmission in Morocco, that’s why CHIKV must be included in the differential diagnosis of arthralgia in all travellers returning from countries with documented transmission of the virus.
“…After leaving worst devastation in different parts of the world, the virus entered Pakistan in 2011 . The emergence of CHIKV outbreak in Karachi, Sindh was reported in 2016 . The Pakistani National Institute of Health reported 7% prevalence of CHIKV in July 2018 whereas, no cases have been confirmed in 2019.…”
Epidemics of infectious diseases especially dengue virus (DENV), chikungunya virus (CHIKV), and poliovirus are the leading cause of mortality and morbidity in Pakistan. Risks associated with these outbreaks have drastic effects on the healthcare infrastructure and economy of the country. This report provides the current status of DENV, poliovirus, and CHIKV in Pakistan and further highlights the measures needed to control these infections.
“…Chikungunya virus also circulates in Pakistan (1), and we believe that factors including climate vagaries, poor sanitation, unchecked border crossings, unplanned urbanization, and changes in agriculture practices contribute to the recent chikungunya outbreak in the country. Moreover, the year 2016 portrayed a dire situation for infectious diseases in Pakistan a dengue epidemic, 19 deaths attributed to CCHF, and first chikungunya outbreak (9, 10).…”
mentioning
confidence: 97%
“…Rauf et al in their recent correspondence in “ Lancet Infectious Diseases ” reported the first chikungunya outbreak in Karachi, Pakistan with 30,000 suspected and 4,000 confirmed cases (1). However, these estimates have been denied in a subsequent report by the National Institute of Health (NIH) indicating 818 suspected and 82 laboratory-confirmed cases of chikungunya (2).…”
mentioning
confidence: 99%
“…However, these estimates have been denied in a subsequent report by the National Institute of Health (NIH) indicating 818 suspected and 82 laboratory-confirmed cases of chikungunya (2). Rauf and colleagues have highlighted warm climate and wretched sanitary conditions as contributing factors of current outbreak and urge national and international health-organizations to address these momentous issues (1). We agree that climatic features and sanitation issues potentially lead to vector proliferation and the importance of these concerns cannot be disregarded.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.